SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Aptus Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

544529

INE15XJ01010

29.1342566

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

109.76

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1769.66	1548.85	1210.63	704.93	327.98	681.34
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1769.66	1548.85	1210.63	704.93	327.98	681.34
Other Income	38.65	16.26	11.04	8.39	3.33	0.77
Stock Adjustments	71.90	4.35	101.36	26.13	-46.72	-17.82
Total Income	1880.21	1569.46	1323.03	739.45	284.59	664.29
EXPENDITURE :
Raw Materials	1147.32	899.88	812.75	460.08	140.15	359.31
Power & Fuel Cost	10.09	9.85	8.39	5.29	2.35	4.72
Employee Cost	103.21	89.35	82.11	66.22	59.87	76.71
Other Manufacturing Expenses	111.95	99.97	86.42	59.45	27.57	52.69
Selling & Administrative Expenses	290.26	207.57	133.88	73.50	44.41	91.61
Miscellaneous Expenses	11.88	8.51	7.29	20.86	12.84	7.58
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1674.71	1315.13	1130.84	685.40	287.19	592.61
Operating Profit	205.50	254.33	192.19	54.06	-2.60	71.68
Interest	7.42	7.45	6.01	4.84	5.79	10.02
Gross Profit	198.08	246.88	186.18	49.22	-8.39	61.66
Depreciation	45.80	43.10	29.00	19.45	20.42	21.50
Profit Before Tax	152.28	203.78	157.18	29.77	-28.81	40.16
Tax	35.52	51.24	34.94	2.66	0.00	11.04
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.77	-1.94	3.30	4.10	-7.96	-1.39
Reported Net Profit	117.53	154.48	118.94	23.01	-20.86	30.51
Extraordinary Items	1.68	1.13	0.16	-7.97	-0.43	-0.12
Adjusted Net Profit	115.85	153.35	118.78	30.98	-20.43	30.63
Adjustment below Net Profit	0.00	0.00	-5.35	0.00	1.74	0.00
P & L Balance brought forward	359.43	215.64	102.05	79.04	98.07	68.90
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	14.65	10.69	0.00	0.00	-0.09	1.35
P & L Balance carried down	462.31	359.43	215.64	102.05	79.04	98.07
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	150.00	200.00	175.00	40.00	0.00	0.00
Dividend Per Share(Rs)	3.00	4.00	3.50	0.80	0.00	0.00
Earnings Per Share-Unit Curr	24.03	31.69	50.19	10.27	-9.32	13.64
Earnings Per Share(Adj)-Unit Curr	24.03	31.69	25.10	5.14	-4.66	6.82
Book Value-Unit Curr	184.21	163.29	177.06	104.08	93.90	102.78
Book Value(Adj)-Unit Curr	184.21	163.29	88.53	52.04	46.95	51.39

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)